- 6 次围观
产品图片
货号/SKU
NR-45895
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-45895??Staphylococcus aureus, LY-1999 0620-03(Bacteria)|Staphylococcus aureus|LY-1999 0620-03|-60°C or colder|NARSAAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain LY-1999 0620-03, NR-45895."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain LY-1999 0620-03 (also referred to as NRS65) was isolated in Oman in 1998 from blood of a 50-year-old female patient with septicemia who had a history of diabetes mellitus, chronic renal failure, renal transplant with subsequent rejection, wound and catheter infections and extended treatment with glycopeptides.
S. aureus, strain LY-1999 0620-03 is a glycopeptide-intermediate S. aureus (GISA) strain. S. aureus, strain LY-1999 0620-03 was deposited as postive for mec (subtype III); negative for vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 372; eGenomic spa type 3, eGenomic spa repeats WGKAOMQ; Ridom spa type t037. Strain LY-1999 0620-03 and strain LY-1999 0620-02 (NRS64) were isolated on the same day from the patient and are related by pulsed-field gel electrophoresis (PFGE).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Staphylococcus aureus (S. aureus), strain LY-1999 0620-03 (also referred to as NRS65) was isolated in Oman in 1998 from blood of a 50-year-old female patient with septicemia who had a history of diabetes mellitus, chronic renal failure, renal transplant with subsequent rejection, wound and catheter infections and extended treatment with glycopeptides.
S. aureus, strain LY-1999 0620-03 is a glycopeptide-intermediate S. aureus (GISA) strain. S. aureus, strain LY-1999 0620-03 was deposited as postive for mec (subtype III); negative for vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 372; eGenomic spa type 3, eGenomic spa repeats WGKAOMQ; Ridom spa type t037. Strain LY-1999 0620-03 and strain LY-1999 0620-02 (NRS64) were isolated on the same day from the patient and are related by pulsed-field gel electrophoresis (PFGE).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID进行批准. 金黄色葡萄球菌(金黄色葡萄球菌),菌株LY-1999 0620-03(也提到由于NRS65)于1998年在阿曼分离出50岁女性患者的血液血症患者,患有糖尿病患者,慢性肾功能衰竭,肾移植随后的排斥,伤口和导管感染以及用糖肽的延长治疗. s. AUREUS ,菌株LY-1999 0620-03是糖肽中间体.金黄色葡萄球菌(GISA)菌株. s.金黄色葡萄球菌,菌株Ly-1999 0620-03沉积为 mec (亚型III); vana, Vanb , Vanc1, Vanc2 , vand 和 vane ; MLST测序类型(ST)372; Egenomic spa 型3,egenomic spa 重复Wgkaomq; RINOM SPA 型T037型.菌株Ly-1999 0620-03和菌株Ly-1999 0620-02(NRS64)在患者的同一天上分离出来,并与脉冲场凝胶电泳(PFGE)相关. 每个小瓶都包含大约0.5ml胰蛋白酶肉汤中的细菌培养物,补充有10%甘油.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2020-08-04
2022-04-01
2022-04-01
2021-12-13
2022-06-17
2021-12-21
2021-12-21
2021-12-02
2021-12-13
2023-10-15
2022-04-01
2022-04-01
2021-12-21
2022-03-31
2022-04-01